150 related articles for article (PubMed ID: 9185122)
1. Oral famotidine: a potential treatment for children with autism.
Linday LA
Med Hypotheses; 1997 May; 48(5):381-6. PubMed ID: 9185122
[TBL] [Abstract][Full Text] [Related]
2. Famotidine treatment of children with autistic spectrum disorders: pilot research using single subject research design.
Linday LA; Tsiouris JA; Cohen IL; Shindledecker R; DeCresce R
J Neural Transm (Vienna); 2001; 108(5):593-611. PubMed ID: 11459079
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of gastrosidine (famotidine) in the treatment of gastroesophageal reflux at the reflux esophagitis stage].
Vasil'ev IuV; Li IA
Eksp Klin Gastroenterol; 2002; (4):30-3, 131. PubMed ID: 12503271
[TBL] [Abstract][Full Text] [Related]
4. Gastroesophageal reflux and histamine2 antagonists.
Bell SG
Neonatal Netw; 2003; 22(2):53-7. PubMed ID: 12696725
[No Abstract] [Full Text] [Related]
5. The tolerability and safety profile of famotidine.
Howden CW; Tytgat GN
Clin Ther; 1996; 18(1):36-54; discussion 35. PubMed ID: 8851452
[TBL] [Abstract][Full Text] [Related]
6. Famotidine augmentation in schizophrenia: hope or hype?
Andrade C
J Clin Psychiatry; 2013 Sep; 74(9):e855-8. PubMed ID: 24107771
[No Abstract] [Full Text] [Related]
7. Famotidine in the management of schizophrenia.
Martinez MC
Ann Pharmacother; 1999 Jun; 33(6):742-7. PubMed ID: 10410190
[TBL] [Abstract][Full Text] [Related]
8. Famotidine for infant gastro-oesophageal reflux: a multi-centre, randomized, placebo-controlled, withdrawal trial.
Orenstein SR; Shalaby TM; Devandry SN; Liacouras CA; Czinn SJ; Dice JE; Simon TJ; Ahrens SP; Stauffer LA
Aliment Pharmacol Ther; 2003 May; 17(9):1097-107. PubMed ID: 12752346
[TBL] [Abstract][Full Text] [Related]
9. [Effect and safety of famotidine for therapy of gastrointestinal bleeding in children].
Chen FB; Huang XL; Chen J; Wu M; Wang J; Zhou X
Zhonghua Er Ke Za Zhi; 2005 Jan; 43(1):64-5. PubMed ID: 15796817
[No Abstract] [Full Text] [Related]
10. [Quamatel efficacy against ulcer].
Nogaller AM; Butov MA; Luniakov AS
Klin Med (Mosk); 1996; 74(9):55-8. PubMed ID: 9121093
[No Abstract] [Full Text] [Related]
11. Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease.
Furuta K; Adachi K; Komazawa Y; Mihara T; Miki M; Azumi T; Fujisawa T; Katsube T; Kinoshita Y
J Gastroenterol Hepatol; 2006 Oct; 21(10):1581-5. PubMed ID: 16928220
[TBL] [Abstract][Full Text] [Related]
12. On the biological treatment of autistic disorder.
Sher L
Med Hypotheses; 1999 May; 52(5):489. PubMed ID: 10416959
[No Abstract] [Full Text] [Related]
13. Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis.
Simon TJ; Roberts WG; Berlin RG; Hayden LJ; Berman RS; Reagan JE
Clin Ther; 1995; 17(6):1147-56. PubMed ID: 8750406
[TBL] [Abstract][Full Text] [Related]
14. Famotidine. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in peptic ulcer disease and other allied diseases.
Langtry HD; Grant SM; Goa KL
Drugs; 1989 Oct; 38(4):551-90. PubMed ID: 2573505
[TBL] [Abstract][Full Text] [Related]
15. A randomized clinical trial of histamine 2 receptor antagonism in treatment-resistant schizophrenia.
Meskanen K; Ekelund H; Laitinen J; Neuvonen PJ; Haukka J; Panula P; Ekelund J
J Clin Psychopharmacol; 2013 Aug; 33(4):472-8. PubMed ID: 23764683
[TBL] [Abstract][Full Text] [Related]
16. [Conservative treatment of ulcer hemorrhage with histamine H2 antagonists].
Grigor'ev PI; Grinberg AA; Toguzova DA; Iakovenko AV; Lopatina IV
Khirurgiia (Mosk); 1997; (5):63-5. PubMed ID: 9297029
[No Abstract] [Full Text] [Related]
17. Famotidine 40mg B.I.D. in the treatment of reflux oesophagitis.
Ahmed W; Qureshi H; Alam SE; Zuberi SJ
J Pak Med Assoc; 1995 Sep; 45(9):241-3. PubMed ID: 8683830
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effects of oral famotidine and ranitidine on gastric volume and pH.
Dubin SA; Silverstein PI; Wakefield ML; Jense HG
Anesth Analg; 1989 Nov; 69(5):680-3. PubMed ID: 2572186
[No Abstract] [Full Text] [Related]
19. Central nervous system reactions associated with famotidine: report of five cases.
Odeh M; Oliven A
J Clin Gastroenterol; 1998 Oct; 27(3):253-4. PubMed ID: 9802455
[TBL] [Abstract][Full Text] [Related]
20. Famotidine: effective treatment of Zollinger-Ellison syndrome.
Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
